Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Dihuang Yinzi Decoction is a traditional Chinese medicine (TCM) herbal formula derived from the classic "Dihuang Yinzi" (Rehmannia Drink). It is primarily utilized in the treatment of neurological conditions, particularly post-stroke complications such as dysphagia (swallowing difficulties) and aphasia. The formula typically consists of a complex mixture of herbs, including *Rehmannia glutinosa*, *Morinda officinalis*, and *Cornus officinalis*, which are traditionally believed to nourish the kidney yin and tonify the kidney yang. Other components like *Acorus tatarinowii* and *Polygala tenuifolia* are included to open the sensory orifices and resolve phlegm. In clinical research, such as that conducted by the Wenzhou Chinese Medicine Hospital, the "modified" version is often tailored to enhance the recovery of swallowing function and is frequently evaluated in combination with swallowing rehabilitation exercises and videofluoroscopic assessment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Dihuang Yinzi Decoction.